Massive perivillous fibrin deposition

From WikiMD's Wellness Encyclopedia

(Redirected from Maternal floor infarction)

Massive Perivillous Fibrin Deposition (MPFD) is a rare placental disorder characterized by the extensive accumulation of fibrin on the chorionic villi of the placenta. This condition is associated with adverse pregnancy outcomes, including fetal growth restriction, stillbirth, and recurrent miscarriage.

Etiology[edit | edit source]

The exact cause of MPFD is unknown. However, it is believed to be associated with maternal autoimmune disorders, thrombophilia, and infections. Some studies suggest that MPFD may be a response to maternal-fetal immune conflict.

Pathophysiology[edit | edit source]

In MPFD, there is an excessive deposition of fibrin, a protein involved in blood clotting, on the chorionic villi of the placenta. This leads to impaired maternal-fetal circulation, resulting in reduced nutrient and oxygen supply to the fetus. The condition can lead to fetal growth restriction, stillbirth, or recurrent miscarriage.

Diagnosis[edit | edit source]

Diagnosis of MPFD is usually made postpartum by histopathological examination of the placenta. Prenatal diagnosis is challenging due to the lack of specific clinical features and imaging findings.

Treatment[edit | edit source]

There is no specific treatment for MPFD. Management is usually supportive and aimed at addressing the associated complications. In some cases, anticoagulant therapy may be considered.

Prognosis[edit | edit source]

The prognosis of MPFD is generally poor, with a high rate of recurrence in subsequent pregnancies. However, with close monitoring and appropriate management, some women with MPFD may have successful pregnancies.

See also[edit | edit source]

Massive perivillous fibrin deposition Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD